Nephritogenic λ light chain dimer: A unique human miniautoantibody against complement factor H

Journal of Immunology

Volumn 163, Issue 8, 1999, Pages 4590-4596

  Jokiranta, T Sakari ^a   Solomon, Alan ^b   Pangburn, Michael K ^c   Zipfel, Peter F ^d   Meri, Seppo ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^d BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENT FACTOR H; DIMER; IMMUNOGLOBULIN LAMBDA CHAIN;

ADULT; ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; COMPLEMENT ALTERNATIVE PATHWAY; CONTROLLED STUDY; FEMALE; HEMOLYSIS; HUMAN; HYPOCOMPLEMENTEMIA; IMMUNOGLOBULIN VARIABLE REGION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN ISOLATION;

AMINO ACID SEQUENCE; AUTOANTIBODIES; BINDING SITES, ANTIBODY; COMPLEMENT FACTOR H; COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT PATHWAY, ALTERNATIVE; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; FEMALE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; IMMUNOGLOBULIN LAMBDA-CHAINS; MIDDLE AGED; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032875669     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Götze, O., and H. J. Müller-Eberhard. 1971. The C3-activator system: an alternate pathway of complement activation. J. Exp. Med. 134(Suppl.):90.
2. Ratnoff, W. D., D. T. Fearon, and K. F. Austen. 1983. The role of antibody in the activation of the alternative complement pathway. Springer Semin. Immunopathol. 6:361.
3. Dempsey, P. W., M. E. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348.
4. Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50.
5. Pangburn, M. K., and H. J. Müller-Eberhard. 1984. The alternative pathway of complement. Springer Semin. Immunopathol. 7:163.
6. Whaley, K., and S. Ruddy. 1976. Modulation of the alternative complement pathway by β1H globulin. J. Exp. Med. 144:1147.
7. Weiler, J. M., M. R. Daha, K. F. Austen, and D. T. Fearon. 1976. Control of the amplification convertase of complement by the plasma protein β1H. Proc. Natl. Acad Sci. USA 73:3268.
8. Pangburn, M. K., and H. J. Müller-Eberhard. 1978. Complement C3 convertase: cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells. Proc. Natl. Acad. Sci. USA 75:2416.
9. Men, S., and M. K. Pangburn. 1990. Discrimination between activators and non-activators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. USA 87:3982.
10. Vik, D. P., P. Munoz-Canoves, D. D. Chaplin, and B. F. Tack. 1990. Factor H. Curr. Top. Microbiol. Immunol. 153:147.
11. Sharma, A. K., and M. K. Pangburn. 1996. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc. Natl. Acad. Sci. USA 93:10996.
12. Jokiranta, T. S., P. F. Zipfel, J. Hakulinen, S. Kühn, M. K. Pangburn, J. D. Tamerius, and S. Men. 1996. Analysis of the recognition mechanism of the alternative pathway of complement by monoclonal anti-factor H antibodies: evidence for multiple interactions between H and surface bound C3b. FEBS Lett. 393:297.
13. Jokiranta, T. S., J. Hellwage, V. Koistinen, P. F. Zipfel, and S. Meri. 1998. Each of the three binding sites on factor H interacts with a distinct site on C3b. Mol. Immunol. 35:360 (Abstr.).
14. West, C. D. 1994. Nephritic factors predispose to chronic glomerulonephritis. Am. J. Kidney Dis. 24:956.
15. Daha, M. R., D. T. Fearon, and K. F. Austen. 1976. C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase. J. Immunol. 116:1.
16. Jansen, J. H., K. Høgåsen, and T. E. Mollnes. 1993. Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease). Am. J. Pathol. 143:1356.
17. Høgåsen, K., J. H. Jansen, T. E. Mollnes, J. Hovdenes, and M. Harboe. 1995. Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. J. Clin. Invest. 95:1054.
18. Thompson, R. A., and M. H. Winterborn. 1981. Hypocomplementaemia due to a genetic deficiency of β1H globulin. Clin. Exp. Immunol. 46:110.
19. Wyatt, R. J., B. A. Julian, A. Weinstein, N. F. Rothfield, and R. H. McLean. 1982. Partial H (β1H) deficiency and glomerulonephritis in two families. J. Clin. Immunol. 2:110.
20. Warwicker, P., T. Goodship, R. Donne, Y. Pirson, A. Nicholls, R. Ward, P. Turnpenny, and J. Goodship. 1998. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int. 53:836.
21. Meri, S., V. Koistinen, A. Miettinen, T. Törnroth, and I. J. Seppälä. 1992. Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis. J. Exp. Med. 175:939.
22. Habib, R. 1973. Classification of glomerulonephritis based on morphology. Perspect. Nephrol. Hyperten. 1:17.
23. Eulitz, M., C. Murphy, D. T. Weiss, and A. Solomon. 1991. Serologic and chemical differentiation of human lambda III light chain variable regions. J. Immunol. 146:3091.
24. Kabat, E. H., T. T. Wu, H. M. Perry, K. S. Gottesman, and C. Foeller. 1991. Sequences of Proteins of Immunological Interest. National Institutes of Health Publications, Washington, DC.
25. Koistinen, V. 1991. Effect of complemem-protein-C3b density on the binding of complement factor H to surface-bound C3b. Biochem. J. 280:255.
26. Koistinen, V., S. Wessberg, and J. Leikola. 1989. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d. Compl. Inflamm. 6:270.
27. Kühn, S., and P. F. Zipfel. 1995. The baculoviras expression vector pBSV-8His directs secretion of histidine-tagged proteins. Gene 162:225.
28. Kühn, S., C. Skerka, and P. F. Zipfel. 1995. Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H. J. Immunol. 155:5663.
29. Saul, F. A., and R. J. Poljak. 1992. Crystal structure of human immunoglobulin fragment Fab New refined at 2.0 Å resolution. Proteins 14:363.
30. Ely, K. R., J. N. Herron, M. Harker, and A. B. Edmundson. 1989. Three-dimensional structure of a light chain dimer crystallized in water: conformational flexibility of a molecule in two crystal forms. J. Mol. Biol. 210:601.
31. Jokiranta, T. S., J. Tissari, O. Teleman, and S. Meri. 1995. Extracellular domain of type I receptor for transforming growth factor-β: molecular modelling using protectin (CD59) as a template. FEBS Lett. 376:31.
32. Barlow, P. N., A. Steinkasserer, D. G. Norman, B. Kieffer, A. P. Wiles, R. B. Sim, and I. D. Campbell. 1993. Solution structure of a pair of complement modules by nuclear magnetic resonance. J. Mol. Biol. 232:268.
33. Ripoche, J., A. J. Day, T. J. Harris, and R. B. Sim. 1988. The complete amino acid sequence of human complement factor H. Biochem. J. 249:593.
34. Frippiat, J. P., and M. P. Lafranc 1994. Genomic organisation of 34 kb of the human immunoglobulin lambda locus (IGLV): restriction map and sequences of new V lambda III genes. Mol. Immunol. 31:657.
35. Ledbetter, J. A., H. P. Fell, L. S. Grosmaire, N. A. Norris, and T. T. Tsu. 1987. An immunoglobulin light chain dimer with CD4 antigen specificity. Mol. Immunol. 24:1255.
36. Tribbick, G., A. B. Edmundson, T. J. Mason, and H. M. Geysen. 1989. Similar binding properties of peptide ligands for a human immunoglobulin and its light chain dimer. Mol. Immunol. 26:625.
37. Winter, G., and C. Milstein. 1991. Man-made antibodies. Nature 349:293.
38. Sun, M., L. Li, Q. S. Gao, and S. Paul. 1994. Antigen recognition by an antibody light chain. J. Biol. Chem. 269:734.
39. Galin, F. S., C. C. Maier, S. R. Zhou, J. N. Whitaker, and J. E. Blalock. 1996. Murine Vλx and Vλx-containing antibodies bind human myelin basic protein. J. Clin. Invest. 97:486.
40. Ward, E. S., D. Gussow, A. D. Griffiths, P. T. Jones, and G. Winter. 1989. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature 341:544.
41. Hamers-Casterman, C., T. Atarhouch, S. Muyldermans, G. Robinson, C. Hamers, E. B. Songa, N. Bendahman, and R. Hamers. 1993. Naturally occurring antibodies devoid of light chains. Nature 363:446.
42. Sim, E., M. S. Palmer, M. Puklavec, and R. B. Sim. 1983. Monoclonal antibodies against the complement control protein factor H (β1H). Biosci. Rep. 3:1119.
43. Alsenz, J., J. D. Lambris, T. F. Schulz, and M. P. Dierich. 1984. Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38 kDa tryptic fragment of factor H. Biochem. J. 224:389.
44. Gordon, D. L., R. M. Kaufman, T. K. Blackmore, J. Kwong, and D. M. Lublin. 1995. Identification of complement regulatory domains in human factor H. J. Immunol. 155:348.